Rivastigmine for the treatment of anticholinergic delirium following severe procyclidine intoxication

M. W Van Kernebeeka Department of Psychiatry, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium

M. Ghesquiereb Department of Emergency Medicine, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium

https://orcid.org/0000-0003-0837-9978

N. Vanderbruggena Department of Psychiatry, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium

E. Verhoevenb Department of Emergency Medicine, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium

I. Hubloueb Department of Emergency Medicine, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium

C. L Crunellea Department of Psychiatry, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium;c Toxicological Center, Antwerp University, Antwerp, BelgiumCorrespondence[email protected]

References

Goldfrank L, Nelson LS, Howland MA, et al. Goldfrank’s toxicologic emergencies. 11th ed. Europe: Mc Graw Hill Education; 2019.
Google Scholar
Arens AM, Kearney T. Adverse effects of Physostigmine. J Med Toxicol. 2019;15(3):184–191.
PubMed Web of Science ®Google Scholar
Dawson AH, Buckley NA. Pharmacological management of anticholinergic delirium - theory, evidence and practice. Br J Clin Pharmacol. 2016;81(3):516–524.
PubMed Web of Science ®Google Scholar
Sandia SI, Ramírez VJ, Piñero AJ, et al. Treating 'Devil’s Breath׳ intoxication: use of rivastigmine in six patients with toxic psychoses due to non pharmaceutical scopolamine. Eur Neuropsychopharmacol. 2017;27(8):833–834.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Rivastigmine for the treatment of anticholinergic delirium following severe procyclidine intoxication

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Rivastigmine for the treatment of anticholinergic delirium following severe procyclidine intoxication

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date